You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...
On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...
The U.S. Government Patient Assistance Program (USG PAP), operated by Pfizer, will provide eligible Medicare beneficiaries with free Paxlovid access until December 31, 2025. Paxlovid is a prescription ...
Gemtesa’s manufacturer offers a patient assistance program called the Gemtesa Simple Savings Program. Depending on your eligibility, this program can help you save on your prescription costs. Gemtesa ...
In its first advisory opinion of the year, the Office of Inspector General for the U.S. Department of Health and Human Services (OIG) assessed a pharmaceutical manufacturer’s free product program and ...
Medicare Part D’s 2026 changes will exclude several common and high-cost drugs, such as Humira, Wegovy, and Viagra, potentially raising out-of-pocket costs for many. While reforms like negotiated ...
Gemtesa’s manufacturer (Urovant Sciences) provides the Gemtesa Simple Savings Program. This is a financial assistance plan aimed at making Gemtesa (vibegron) — a treatment for overactive bladder in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results